Intervention Protocol

Role of rituximab for first-line or relapsed aggressive B-cell lymphoma

  1. Christina Fitzmaurice*,
  2. Brad Kahl

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 5 OCT 2011

DOI: 10.1002/14651858.CD009347


How to Cite

Fitzmaurice C, Kahl B. Role of rituximab for first-line or relapsed aggressive B-cell lymphoma (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD009347. DOI: 10.1002/14651858.CD009347.

Author Information

  1. University of Wisconsin Hospital and Clinics, Department of Internal Medicine, Madison, WI, USA

*Christina Fitzmaurice, Department of Internal Medicine, University of Wisconsin Hospital and Clinics, 600 Highland Ave, Madison, WI, 53705, USA. cfitzmaurice@uwhealth.org.

Publication History

  1. Publication Status: New
  2. Published Online: 5 OCT 2011

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.